This does not only suggest that CD63 plays a critical and specific role in kidney pathology, and consequently in kidney tumorigenesis, but also hints that CD63 can be a therapeutic target for kidney cancer with minimal systemic toxicity. This evidence concerns the gene CD63 and kidney cancer.